Company Profile | February 28, 2014

2014 CRO Leadership Awards Winner

surpass logo

Categories Won:

  1. Quality

  2. Reliability

  3. Regulatory

  4. Productivity

  5. Innovation


Drug Life Cycle Stages:
Research & Development: Preclinical

Main Service Areas:

Services & Capabilities:
Preclinical services for the development, characterization, and evaluation of medical devices,  pharmaceuticals, biologics, and combination products with expertise in large animal surgical and interventional procedures. A proven track record performing proof-of-concept through GLP safety studies with case experience in PK, wound healing, infusion pumps, valves, spinal fusion, renal denervation, vascular grafts/stents, ablation systems, and more

Therapeutic Areas:
Cardiovascular, orthopedic, dermatological, neurological, urogenital, pulmonary, gastrointestinal, reproductive, and more

Tim Pelura, Ph.D.

president and CEO

“Surpass is grateful to our clients for these CRO Leadership Awards which recognize our dedicated, experienced team as a true partner  delivering translational scientific data that moves novel medical therapies to market.”